SCM
XERS icon

Stonepine Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Stonepine Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,030
Closed -$256K – 106
2026
Q1 		$232K Buy
+40,030
New +$265K 0.09% 69
2025
Q3 		– Sell
-205,100
Closed -$958K – 76
2025
Q2 		$958K Buy
205,100
+102,835
+101% +$471K 0.94% 28
2025
Q1 		$561K Sell
102,265
-80,052
-44% -$323K 0.55% 37
2024
Q4 		$618K Buy
+182,317
New +$586K 0.5% 38
2024
Q2 		– Sell
-598,086
Closed -$1.32M – 31
2024
Q1 		$1.32M Sell
598,086
-5,338,914
-90% -$13.8M 1.05% 15
2023
Q4 		$14M Buy
5,937,000
+21,628
+0.4% +$39.9K 6.03% 6
2023
Q3 		$11M Buy
5,915,372
+415,144
+8% +$951K 3.66% 8
2023
Q2 		$14.4M Sell
5,500,228
-3,139,977
-36% -$7.99M 5.2% 7
2023
Q1 		$14.1M Sell
8,640,205
-2,554,984
-23% -$3.2M 4.72% 6
2022
Q4 		$14.9M Sell
11,195,189
-1,732,979
-13% -$2.45M 6.26% 6
2022
Q3 		$20.2M Buy
12,928,168
+1,280,751
+11% +$2.12M 9.07% 4
2022
Q2 		$17.9M Buy
11,647,417
+3,723,361
+47% +$7.86M 8.35% 3
2022
Q1 		$20.3M Buy
7,924,056
+2,267,683
+40% +$5.54M 8.41% 3
2021
Q4 		$16.6M Buy
+5,656,373
New +$12.2M 7.61% 3

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Stonepine Capital Management's XERS Position: Q2 2026 in Review

Stonepine Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 40,030 shares — an estimated $256K sold.

Stonepine Capital Management first reported a position in XERS in Q4 2021 and held it in 14 quarters. The position peaked at $20.3M in Q1 2022. 239 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Stonepine Capital Management reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Stonepine Capital Management sold 40,030 Xeris Biopharma Holdings shares in Q2 2026, an estimated $256K.
  • Stonepine Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 14 quarters.
  • Stonepine Capital Management's Xeris Biopharma Holdings position peaked at $20.3M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.